The EPS projection of Ophthotech Corporation (NASDAQ:OPHT) for quarter ended 2016-09-30 is $-1.17. Last week, the EPS forecast was $-1.17 against target of $-1.17, a month earlier. Two months ago, this estimate was $-1.17 versus forecast of $-1.17 three months earlier, implying a deviation of 0%.
Ophthotech Corporation (NASDAQ:OPHT) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 2, 2, and 2, correspondingly.
EPS estimate downgrade for Ophthotech Corporation (NASDAQ:OPHT) in the preceding 30, 120, 60 and 90 days were 0, 2, 3, and 2, correspondingly.
Ophthotech Corporation (NASDAQ:OPHT) EPS target for the quarter closed 1 was $-1.17, based on 5 recommendations. As reported on 2016-05-04 the EPS was $-1.03. The change was $0.29, implying a percentage deviation of 21.97%. The projections showed a standard deviation of 0.12.
Quarterly Sales Estimates
Ophthotech Corporation (NASDAQ:OPHT) yearly sales prediction for the fiscal 2016 stands at $19.36 and the median estimate is at $6.48. Almost 3 analysts issued sales target.
Highest sales target is $49.5 while the lowest target is $2.1 showing standard deviation of 26.193%.
As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 0%.
Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast. Ophthotech Corporation (NASDAQ:OPHT) announced that the deviation in forecast was 0%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...